Loading icon
Categories
Bioinformatics
2
Genetics
10
Art and Literature
3
Tutorials
6
Multiple Sclerosis
5
Omics
2
Trending post
1
A Blood Test for Progressive MS? What the Metabolite Signature Actually Shows
Genetics
A Blood Test for Progressive MS? What the Metabolite Signature Actually Shows

02, Sep 2026

2
A Blood Test for Progressive MS? What the Metabolite Signature Actually Shows
Genetics
Metabolism as Medicine: A New Therapeutic Direction for Multiple Sclerosis

01, Sep 2026

3
Twelve Genes, Twenty Years, No Answer: Vitamin D and Genetic Susceptibility to MS
Genetics
Twelve Genes, Twenty Years, No Answer: Vitamin D and Genetic Susceptibility to MS

31, Aug 2026

4
Metabolites and Multiple Sclerosis: What Genetic Studies Agree and Disagree On
Genetics
Metabolites and Multiple Sclerosis: What Genetic Studies Agree and Disagree On

30, Aug 2026

5
Inflammation–Metabolite in Multiple Sclerosis: The Emerging Role of Interleukin-7
Genetics
Inflammation–Metabolite in Multiple Sclerosis: The Emerging Role of Interleukin-7

29, Aug 2026

Categories:
Genetics
Leveraging Autoimmune Genetic Correlation to Expand Multiple Sclerosis Risk Loci: Meta-analysis and Proxy-Phenotype Discovery
Genetics
Leveraging Autoimmune Genetic Correlation to Expand Multiple Sclerosis Risk Loci: Meta-analysis and Proxy-Phenotype Discovery

01, Mar 2026

Differential Performance of Genetic Risk Scores for Multiple Sclerosis Across European, Latino/Admixed, and African Ancestry: Evidence From
Genetics
Differential Performance of Genetic Risk Scores for Multiple Sclerosis Across European, Latino/Admixed, and African Ancestry: Evidence From

02, Mar 2026

A Proteomic Atlas of Cerebrospinal Fluid at Scale: Recalibrating Biomarkers and Staging in Multiple Sclerosis
Genetics
A Proteomic Atlas of Cerebrospinal Fluid at Scale: Recalibrating Biomarkers and Staging in Multiple Sclerosis

02, Mar 2026

Genetic Liability and Early-Life Exposures Shape the Timing of Multiple Sclerosis Diagnosis: Evidence From a UK Biobank Survival Analysis
Genetics
Genetic Liability and Early-Life Exposures Shape the Timing of Multiple Sclerosis Diagnosis: Evidence From a UK Biobank Survival Analysis

04, Mar 2026